Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats

Chinese Medical Journal

Volumn 122, Issue 20, 2009, Pages 2449-2454

  Yang, Xin Xin ^a   Xue, Shou Ru ^a   Dong, Wan Li ^a   Kong, Yan ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor; Human amniotic epithelial cell; Parkinson's disease; Transplantation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NESTIN; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; VIMENTIN;

AMNIOTIC FLUID CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; THERAPY EFFECT;

AMNION; ANIMALS; APOMORPHINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; FEMALE; HOMOVANILLIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70350726774     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.20.010     Document Type: Article

References (22)

1. Sherer TB, Betarbet R, Greenamyre JT. Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2001; 2: 657-662.
2. Le Couteur DG, Muller M, Yang MC, Mellick GD, McLean AJ. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev Environ Health.2002; 17: 51-64. (Pubitemid 34984324)
3. Li X, Yin J, Cheng CM, Sun JL, Li Z, Wu YL. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Chin Med J 2005; 118: 1357-1361. (Pubitemid 41223172)
4. Lee FJ, Liu F. Genetic factors involved in the pathogenesis of Parkinson's disease. Brain Res Rev 2008; 58: 354-364.
5. Yamashita H, Matsumoto M. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease. Regen Med 2007; 2: 447-455. (Pubitemid 47307223)
6. Jankovic J. Parkinson's disease therapy: treatment of early and late disease. Chin Med J 2001; 114: 227-234. (Pubitemid 32231944)
7. Ming M, LE WD. Retinal pigment epithelial cells: biological property and application in Parkinson's disease. Chin Med J 2007; 120: 416-420. (Pubitemid 46488355)
8. Jiang CC, Xia Y, Ding ZL. Effects of co-engraftment of Schwann cells with neural stem cells into rats with Parkinson disease. Chin Med J 2006; 119(12): 1030-1033. (Pubitemid 43960085)
9. Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. 2008; 52: 1332-1342.
10. Adinolfi M, Akle CA, McColl I, Fensom AH, Tansley L, Connolly P, et al. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature 1982; 295: 325-327.
11. Sakuragawa N, Thangavel R, Mizuguchi M, Hirasawa M, Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett 1996; 209: 9-12. (Pubitemid 26150413)
12. Carlsson T, Winkler C, Burger C, Muzyczka N, Mandel RJ, Cenci A, et al. Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. Brain 2005; 128(Pt 3): 559-569. (Pubitemid 40380191)
13. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol 2000; 165: 27-34.
14. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells.Stem Cells 2005; 23: 1549-1559.
15. Tamagawa T, Oi S, Ishiwata I, Ishikawa H, Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 2007; 20: 77-84.
16. Enosawa S, Sakuragawa N, Suzuki S. Possible use of amniotic cells for regenerative medicine. Nippon Rinsho 2003; 61: 396-400.
17. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential.Biol Reprod 2007; 77: 577-588.
18. Ishii T, Ohsugi K, Nakamura S, Sato K, Hashimoto M, Mikoshiba K,et al. Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system. Neurosci Lett 1999; 268: 131-134.
19. Elwan MA, Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 1997; 8: 3435-3438. (Pubitemid 27497459)
20. Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, Y, et al. Protective effects of neurotrophic factors secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cell Dev 2009. Epub ahead of print.
21. Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 2000; 859: 286-292
22. Fan W, Yang Z, Deng L. Basic study on the development of amniotic membrane and its application. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006; 20: 65-68.